← Back to Clinical Trials
Recruiting NCT05726708

NCT05726708 Impact of an E-Learning Coaching for Parents of Young Children With Autism

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05726708
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire Vaudois
Condition Autism Spectrum Disorder
Study Type INTERVENTIONAL
Enrollment 99 participants
Start Date 2023-10-24
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 24 Months
Max Age 48 Months
Study Type INTERVENTIONAL
Interventions
E-Learning

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 99 participants in total. It began in 2023-10-24 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to evaluate the impact of a parental coaching based on E-Learning (EL), intended for parents of children with autism spectrum disorder (ASD). Population: parents of young children (2 to 4 years old) with an ASD diagnosis. The main questions that our study will answer are: * Has parental coaching via E-Learning a significant impact compared to no coaching? * If so, is that impact comparable to standard parental coaching such as PACT? The impact will be evaluated in three domains: * Child development: behavior, sleep, eating behavior * Parental competences: stress, coping, feeling of parental competencies * Parent-child interaction: communication, visual attention The investigators will compare 3 groups: 1. ASD children whose parents will follow a parental coaching via E-learning, 2. ASD children whose parents will follow a standard parental coaching (PACT) 3. ASD children whose parents will not follow any specific coaching program

Eligibility Criteria

Inclusion Criteria: * Children with ASD * Age 2 years to 4 years and 6 months * Family speaking french * Parent who signed the consent form Exclusion Criteria: * children with known genetic syndrome * children with visual or auditive deficit * children with epilepsy * no internet access * no french speaking

Contact & Investigator

Central Contact

Nadia Chabane

✉ nadia.chabane@chuv.ch

📞 +41314 58 94

Frequently Asked Questions

Who can join the NCT05726708 clinical trial?

This trial is open to participants of all sexes, aged 24 Months or older, up to 48 Months, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05726708 currently recruiting?

Yes, NCT05726708 is actively recruiting participants. Contact the research team at nadia.chabane@chuv.ch for enrollment information.

Where is the NCT05726708 trial being conducted?

This trial is being conducted at Lausanne, Switzerland.

Who is sponsoring the NCT05726708 clinical trial?

NCT05726708 is sponsored by Centre Hospitalier Universitaire Vaudois. The trial plans to enroll 99 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology